Henry Meds vs Mochi Health: Cash Compounding vs Insurance

This article lives in the PlexusDx Education Hub, our evidence-based collection on GLP-1 therapy, weight management protocols, and the genetics behind metabolic decisions. Browse all Peptides & GLP-1 education

Consider this independent editorial coverage. PlexusDx has no commercial relationship with Henry Meds or Mochi Health, places no affiliate links, and takes no payment for either mention.

Full head-to-head: PlexusDx vs Henry Meds →

People comparing Henry Meds and Mochi Health are often really comparing two ways to pay for GLP-1 care: a cash-pay compounding program versus a service that leans on insurance support. This editorial walks through that access distinction, the mechanics behind each, and the genetic variable neither brand measures. As of April 2026 the field is broad; we stay on the two named brands.

Two different routes to the same molecules

The headline contrast here is access strategy. Henry Meds is a cash-pay, compounding-centric program, whereas Mochi Health folds insurance navigation into its offering. That single difference reshapes how you might pay, what paperwork is involved, and which medication formats are realistic for you.

How Mochi Health approaches coverage

Mochi Health operates as telehealth with insurance support, meaning it works to help eligible members use coverage where possible. Plans, medication options, and pricing vary and change, so confirm the current picture at Mochi Health's official website when you evaluate it.

How Henry Meds approaches access

Henry Meds pairs virtual evaluation with a compounded-pharmacy pathway on a cash-pay basis, routing either brand-name FDA-approved GLP-1 products or compounded semaglutide and tirzepatide through licensed pharmacies. Details sit on Henry Meds's official website.

What coverage does and does not change about cost

In the 2026 GLP-1 telehealth market, monthly totals frequently range from about $200 to $700 or more once program fees, medication, and compounded dispensing are included. Insurance support can lower out-of-pocket spend for members who qualify, while cash-pay compounding trades coverage for predictability. Because both Henry Meds and Mochi Health publish their own numbers and coverage varies by plan, verify current pricing and any coverage terms directly on each brand's site before deciding.

Coverage aside, the compound sets the pharmacology

However you pay, the biology comes from the drug. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide act on appetite, satiety, and gastric emptying. The trials studied compounds, not payment models: STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024). Outcomes vary with dose, compound, and person.

The pathway biology no plan reimburses for

Neither insurance support nor cash-pay compounding evaluates the inherited architecture behind a GLP-1 response. MC4R anchors satiety and energy balance, FTO shapes fat-mass and obesity risk, GLP1R encodes the receptor GLP-1 compounds bind, and TCF7L2 connects to glucose regulation and GLP-1 secretion. These pathway-level markers do not predict how you will respond, but they map the terrain a clinician prescribes into. PlexusDx pairs its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — with the Precision Peptide Genetic Test, reading 14 pathways, 49 peptides, 150+ genetic insights across FTO, MC4R, and TCF7L2. It is the test before you invest approach: understand your baseline first, then decide with your provider.

Not affiliated: PlexusDx has no affiliation with Henry Meds or Mochi Health and no commercial tie to any company reviewed here.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds or Mochi Health and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

To see how PlexusDx handles this, review the Weight Management Protocols or begin with the Precision Peptide Genetic Test to understand your GLP-1 pathway.

Frequently Asked Questions

Does Mochi Health take insurance?

Mochi Health builds insurance support into its model and works to help eligible members use coverage, whereas Henry Meds runs a cash-pay compounding program. Coverage outcomes depend on your plan and medical eligibility. Confirm exactly what Mochi can bill to insurance on its own site before enrolling.

Is cash-pay compounding more expensive than using insurance?

Not always. Insurance support may reduce out-of-pocket cost when a plan covers GLP-1 therapy, but coverage is not guaranteed and can involve prior authorization. Cash-pay compounding offers a predictable price without insurance. Compare both against your specific plan before assuming which route costs less.

Will the Precision Peptide Genetic Test tell me if a drug will work?

No. It does not predict response to Mochi Health, Henry Meds, or any compound. It reports pathway-level variants in FTO and MC4R, and TCF7L2 that describe your baseline GLP-1 and appetite biology — context that applies whether you pay cash or use coverage.

How does PlexusDx position itself here?

PlexusDx dispenses semaglutide and tirzepatide through its Weight Management Protocols and adds the Precision Peptide Genetic Test for genetic context. The differentiator is pathway-level insight into FTO, MC4R variants, which cash-pay and insurance-support programs alike do not pair with the medication.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education